Plasma cortisol, urinary I7-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction M. P. Chopra,' U. Thadani,2 Clive P. Aber, R. W. Portal, and J. Parkes From the Department of Cardiology, Kingston General Hospital, Hull; and Hull Royal Infirmary Serial estimations ofplasma cortisol were made on 24 patients with acute myocardial infarction. Raised levels were found in 23 patients. The maximal level was observed within 12 hours of infarction in 78 per cent and between I2 and 24 hours in 22 per cent ofpatients. A positive correlation was found between the maximal cortisol level and the maximal levels of serum aspartate aminotransferase and a-hydroxybutyrate dehydrogenase.
There was no significant difference between the maximal level in iS5 patients with an uncomplicated course and 5 patients who developed primary ventricular fibrillation. The maximal level was significantly higher in 4 patients who died with pump failure.
There was no clear relation between a changing plasma cortisol level and the occurrence of ventricular arrhythmias.
The duration of the cortisol rise varied from ii hours to 7 days, and was unrelated to the clinical course or to the maximal cortisol or serum enzyme levels.
No correlation was found between the maximal plasma cortisol level and the initial 24-hour urinary 17-hydroxycorticoids or vanilyl mandelic acid excretion.
Pain, tissue necrosis, and acute circulatory disturbances may provoke adrenocortical and medullary responses. After acute myocardial infarction raised plasma cortisol (Oka, I956; Klein and Palmer, I963; Logan and Murdoch, I966; Bailey, Abernethy, and Beaven, I967; Jacobs and Nabarro, I969) In the present study we have attempted to relate adrenocortical and medullary activity to the clinical course of acute myocardial infarction and especially to the occurrence of major arrhythmias.
Patients and methods
Twenty-four patients (22 men and 2 women) with acute myocardial infarction were studied. The age range was 40 to 72 years. All were admitted to a coronary care unit (Aber, Portal, and Chopra, I969) Group 2 (5I *4pg ±1ii8,tg) were significantly higher than in the control group (I7-2 jug ± 5.4 ug) -P <0o02. The mean level in Group 2 was not significantly different from that in Group I (P >07). There was a highly significant difference between the maximal plasma cortisol levels in Group 3 (II2.7Pg±32/Lg) and Groups i and 2 (P < O-OOOI).
A significant linear correlation (P<o-oi) was noted between the maximal plasma cortisol levels and the maximal serum enzyme levels.
In Group 2 the maximal plasma cortisol levels were observed immediately after successful resuscitation from primary ventricular fibrillation in 4 patients. A raised plasma cortisol level (40 t±g/io ml) was also observed after resuscitation in the fifth patient, though the maximal level (60 ,ug/Ioo ml) occurred 14 hours later as a second peak (Fig. 2) in association with unifocal ventricular ectopic activity. Two other patients showed frequent unifocal ectopic activity coincidental with their maximal plasma cortisol levels.
The highest plasma cortisol levels were observed in patients in Group 3 in association with severe metabolic acidosis, but no constant relation was noted between the maximal plasma cortisol levels and the arterial oxygen tension. Fig. 3 ). The duration of the plasma cortisol increase was unrelated to the maximal cortisol level, the maximal level of serum enzymes, the presence of initial sinus bradycardia (heart rate less than 6o a minute), or the occurrence of frequent ventricular ectopic activity. ii) Four patients showed a double peak cortisol curve within 24 hours of infarction (3 in Group i and i in Group 2). The first peak was observed 2 to 9 hours after infarction. The second peak was seen between 8 and 24 hours after infarction (Curve B, Fig. 3 ). In i patient the second peak developed at the time of unifocal ventricular ectopic activity (Fig. 2) .
Patterns of adrenal response
In 3 it was unrelated to any obvious clinical event.
iii) One patient experienced a second myocardial infarction with acute pulmonary oedema on the 14th day and showed a further substantial rise of the plasma cortisol levels (Curve C, Fig. 3 Neither the maximal plasma cortisol level nor the duration of cortisol increase appeared to relate to the use of heparin.
Urinary 17-OHCS (2I patients) The 24-hour urinary 17-OHCS excretion on the first day after myocardial infarction was within the control range (14.3 mg ± 3) in 3 patients (2 in Group i and i in Group 2) and low in 3 patients (Group i). Increased excretion occurred in IS patients (7I%) (io in Group i, 4 in Group 2 and i in Group 3); 9 of these showed a prolonged cortisol rise and 2 a double peak. There was no correlation between the 24-hour urinary I7-OHCS excretion and the maximal plasma cortisol level. The urinary I7-OHCS had returned to the control range or below within I4 days of infarction in all patients except one (Fig. 4) .
Urinary VMIA (2I patients) The 24-hour urinary excretion of VMA on the first day after myocardial infarction was within the control range (5 6 mg ± i) or below in I7 patients (8i%) -I2 in Group i and 5 in Group 2. Four patients (3 in Group i) and i in Group 3) showed high VMA excretion. Two of them had persistent sinus tachycardia and one was in pulmonary oedema. There was an overall significant fall of VMA levels (P < 0-02) 
Discussion
The results of the present investigation confirm previous reports that the plasma cortisol level is almost invariably raised after myocardial infarction (Oka, I956; Klein and Palmer, I963; Logan and Murdoch, I966; Bailey et al., I967) and that the diurnal variation of plasma cortisol secretion is lost under these circumstances (Logan and Murdoch, I966) . Similar adrenocortical responses have been found in association with acute infections, acute psychological stress, and metabolic disturbances (Perkoff et al., 1954; Klein et al., 1955;  Murray, I967; Jacobs and Nabarro, I969; Levi, I969 (Fig. 3) after sustaining a further myocardial infarction on the fourteenth day. Even so, a beneficial effect from massive doses of corticosteroids has been claimed in cardiogenic shock (Alexander and Azzam, I969) . This, however, has been ascribed to induced vasodilatation and does not imply pre-existing adrenal exhaustion (Lillehei et al., I964) .
The failure to find any obvious relation between the urinary VMA excretion and either the plasma cortisol response or the clinical progress of the patients in this study, is perhaps only to be expected since this measurement is now known to be only a crude index of adrenomedullary activity (Ceremuzynski et al., 1970) . 
